The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 15, 2026
Filed:
Oct. 20, 2023
Applicants:
Emory University, Atlanta, GA (US);
Children's Healthcare of Atlanta, Inc., Atlanta, GA (US);
Inventor:
Claudia R. Morris, Atlanta, GA (US);
Assignees:
Emory University, Atlanta, GA (US);
Children's Healthcare of Atlanta, Inc., Atlanta, GA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A23L 33/12 (2016.01); A23L 33/00 (2016.01); A23L 33/135 (2016.01); A23L 33/15 (2016.01); A23L 33/155 (2016.01); A23L 33/16 (2016.01); A23L 33/175 (2016.01); A61K 9/00 (2006.01); A61K 31/047 (2006.01); A61K 31/07 (2006.01); A61K 31/122 (2006.01); A61K 31/19 (2006.01); A61K 31/20 (2006.01); A61K 31/202 (2006.01); A61K 31/205 (2006.01); A61K 31/22 (2006.01); A61K 31/23 (2006.01); A61K 31/231 (2006.01); A61K 31/232 (2006.01); A61K 31/355 (2006.01); A61K 31/375 (2006.01); A61K 31/385 (2006.01); A61K 31/4375 (2006.01); A61K 31/473 (2006.01); A61K 31/59 (2006.01); A61K 31/661 (2006.01); A61K 31/7004 (2006.01); A61K 33/18 (2006.01); A61K 33/24 (2019.01); A61K 33/26 (2006.01); A61K 33/30 (2006.01); A61K 33/32 (2006.01); A61K 33/34 (2006.01); A61K 33/42 (2006.01); A61K 35/741 (2015.01); A61K 38/46 (2006.01); A61K 45/06 (2006.01); A61K 9/14 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/23 (2013.01); A23L 33/12 (2016.08); A23L 33/135 (2016.08); A23L 33/15 (2016.08); A23L 33/155 (2016.08); A23L 33/16 (2016.08); A23L 33/175 (2016.08); A23L 33/40 (2016.08); A61K 9/0056 (2013.01); A61K 31/047 (2013.01); A61K 31/07 (2013.01); A61K 31/122 (2013.01); A61K 31/19 (2013.01); A61K 31/20 (2013.01); A61K 31/202 (2013.01); A61K 31/205 (2013.01); A61K 31/22 (2013.01); A61K 31/231 (2013.01); A61K 31/232 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/385 (2013.01); A61K 31/4375 (2013.01); A61K 31/473 (2013.01); A61K 31/59 (2013.01); A61K 31/661 (2013.01); A61K 31/7004 (2013.01); A61K 33/18 (2013.01); A61K 33/24 (2013.01); A61K 33/26 (2013.01); A61K 33/30 (2013.01); A61K 33/32 (2013.01); A61K 33/34 (2013.01); A61K 33/42 (2013.01); A61K 35/741 (2013.01); A61K 38/46 (2013.01); A61K 45/06 (2013.01); A23V 2002/00 (2013.01); A61K 9/145 (2013.01); A61K 9/2013 (2013.01); A61K 9/4858 (2013.01); A61K 2035/115 (2013.01);
Abstract
Disclosed are nutritional formulations and uses for treating or preventing a gastrointestinal condition and/or motor-planning speech and/or coordination difficulties. In certain embodiments, the nutritional formulations comprise medium chain fatty acids, or esters thereof (such as and tri-, di-, mono-glycerides, or alkyl esters), unsaturated fatty acids, and a vitamin E and optionally other nutrients. In certain embodiments, any of the compounds or nutrients may be in alternative salt forms.